Some additional AHA 2018 presentations of interest to bromodomain/BET inhibition:

Bromodomain and Pulmonary Hypertension: is there any Therapeutic Value?(No abstract available)

BRD4 Antagonist RVX208 Reverses Vascular Remodeling and Supports the Right Ventricle in Pulmonary Arterial Hypertension via PLK1 and FoxM1

Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension -High-Throughput Screening of 5,562 Compounds-(Abstract mentions bromodomain/BET/BRD4)